Sunscreen composition
US-2016303020-A1 · Oct 20, 2016 · US
US10413498B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10413498-B2 |
| Application number | US-201515528530-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 14, 2015 |
| Priority date | Nov 25, 2014 |
| Publication date | Sep 17, 2019 |
| Grant date | Sep 17, 2019 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure relates to agents for dyeing keratin fibers, in particular human hair, containing, in a cosmetic carrier (a) at least one direct dye of formula (I), wherein Y1, Y2 independently represent a nitrogen atom or a group C—R9, and Q represents a special linker group of formula (II), (III), (IV) or (V), (b) at least one anionic surfactant and/or at least one cationic surfactant.
Opening claim text (preview).
The invention claimed is: 1. An agent for dyeing keratinous fibers, the agent comprising, in a cosmetic carrier, (a) at least one direct dye of formula (I), wherein R1, R2, R3, R4 represent, independently of one another, a C 1 -C 6 alkyl group, a C 2 -C 6 alkenyl group, or a hydroxy C 2 -C 6 alkyl group; R5, R6 represent, independently of one another, a hydrogen atom, a C 1 -C 6 alkyl group, a C 2 -C 6 alkenyl group, a hydroxy C 2 -C 6 alkyl group, or a cyano C 1 -C 6 alkyl group; R7, R8 represent, independently of one another, a hydrogen atom, a C 1 -C 6 alkyl group, a halogen atom from the group consisting of chlorine, bromine, fluorine, and/or iodine, or a C 1 -C 6 alkoxy group; wherein at least one of R5, R6, R7, and R8 does not represent a hydrogen atom; X1, X2 represent, independently of one another, a physiologically acceptable anion, chloride, bromide, iodide, methyl sulfate, methyl sulfonate, p-toluenesulfonate, acetate, hydrogen sulfate, ½ sulfate, or ½ tetrachlorozincate; Q represents a group of formula (II); *—(CH 2 ) n -* (II) n represents an integer from 3 to 6; and (b) at least one anionic surfactant and/or at least one cationic surfactant. 2. The agent according to claim 1 , wherein the agent comprises (a) at least one direct dye of general formula (I), in which R1, R2, R3, R4 represent, independently of one another, a methyl group or an ethyl group, and R5, R6 represent, independently of one another, a hydrogen atom, a methyl group, or an ethyl group. 3. The agent according to claim 1 , wherein the agent comprises (a) at least one direct dye of general formula (I), in which R7, R8 each represent a hydrogen atom. 4. The agent according to claim 1 , wherein the agent comprises (a) at least one direct dye of general formula (I) which is selected from: salts of 5-[2-(4-{[3-({4[2-(1,4-dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}amino)propyl]amino}phenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[4-({4-[2-(1,4-Dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}amino)butyl)amino)phenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[5-({4-[2-(1,4-Dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}amino)pentyl]amino}phenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[3-({4[2-(1,4-Dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(methyl)amino)propyl](methyl)amino}phenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[4-({4-[2-(1,4-Dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(methyl)amino)butyl)(methyl)amino]phenyl}diazen-1-yl)-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[5-({4[2-(1,4-Dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(methyl)amino)pentyl](methyl)amino}phenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[4-({4-[2-(1,4-Dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(ethyl)amino)propyl](ethyl)amino}phenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[4-({4-[2-(1,4-Dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(ethyl)amino)butyl](ethyl)amino}phenyl)diazen-1-yl]-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[5-({4[2-(1,4-Dimethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(ethyl)amino)pentyl](ethyl)amino}phenyl}diazen-1-yl)-1,4-dimethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[3-({442-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl}phenyl)-amino]propyl}amino}(phenyl)diazen-1-yl]-1,4-diethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[4-({4-[2-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl]-amino)butyl]amino}phenyl)diazen-1-yl]-1,4-diethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[5-({4[2-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}amino)pentyl]amino}phenyl)diazen-1-yl]-1,4-diethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[3-({4[2-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(methyl)amino)propyl](methyl)amino}phenyl)diazen-1-yl]-1,4-diethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[4-({4-[2-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(methyl)amino)butyl)(methyl)amino]phenyl}diazen-1-yl)-1,4-diethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[5-({4-[2-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(methyl)amino)pentyl](methyl)amino}phenyl)diazen-1-yl)-1,4-diethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[3-({4[2-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(ethyl)amino)propyl](ethyl)amino}phenyl)diazen-1-yl]-1,4-diethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[4-({4-}2-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl)phenyl}-(ethyl)amino]butyl}(ethyl]amino]phenyl)diazen-1-yl]-1,4-diethyl-1H-1,2,4-triazol-4-ium, salts of 5-[2-(4-{[5-({4-[2-(1,4-Diethyl-1H-1,2,4-triazol-4-ium-5-yl)diazen-1-yl]phenyl}-(ethyl)amino)pentyl](ethyl)amino}phenyl)diazen-1-yl]-1,4-diethyl-1H-1,2,4-triazol-4-ium. 5. The agent according to claim 1 , wherein the agent comprises, relative to the total weight of the agent, one or more direct dyes (a) of formula (I) in a total amount of about 0.01 to about 4.5% by weight. 6. The agent according to claim 1 , wherein the agent comprises (b) at least one anionic surfactant selected from: linear and branched fatty acids having 8 to 30 C atoms; ether carboxylic acids of formula R—O—(CH 2 —CH 2 O) x —CH 2 —COOM, in which R represents a linear alkyl group having 8 to 30 C atoms, x represents an integer from 0 to 16, M represents hydrogen, a metal, an alkali metal, sodium, potassium, lithium, an alkaline-earth metal, ½ magnesium, ½ calcium, ½ zinc, or an ammonium ion (NH 4 + ); acyl sarcosides having 8 to 24 C atoms in the acyl group; acyl taurides having 8 to 24 C atoms in the acyl group; acyl isethionates having 8 to 24 C atoms in the acyl group that can be obtained by esterification of C 8 -C 24 fatty acids with the sodium salt of 2-hydroxyethane sulfonic acid (isethionic acid), amide ether carboxylic acids, R 1 CO—NR 2 —CH 2 CH 2 —O—(CH 2 CH 2 O) y CH 2 COOM, wherein R 1 represents a C 2 -C 30 alkyl group, y represents an integer from 1 to 20, R 2 represents hydrogen or a methyl, ethyl, propyl, isopropyl, n-butyl, t-butyl, or isobutyl residue; and M represents hydrogen, a metal, an alkali metal, sodium, potassium, lithium, an alkaline-earth metal, ½ magnesium, ½ calcium, ½ zinc, or an ammonium ion (NH 4 + ). 7. The agent according to claim 1 , wherein the agent comprises, as the anionic surfactant, (b) at least one ether carboxylic acid of formula (B1), R—O—(CH 2 —CH 2 O) x —OH 2 —COOM (B1), wherein R represents a linear alkyl group having 8 to 30 C atoms, x represents an integer from 5 to 11; M represents hydrogen, a metal, an alkali metal, sodium, potassium, lithium, an alkaline-earth metal, ½ magnesium, ½ calcium, ½ zinc, or an ammonium ion (NH 4 + ). 8. The agent according to claim 1 , wherein the agent comprises, relative to the total weight of the agent, one or more anionic surfactants (b) in a total amount of about 0.05 to about 4.5% by weight. 9. The agent according to claim 1 , wherein the agent comprises, as the cationic surfactant, (b) one or more compounds of formula (B2), wherein Ra, Rb represent, independently of one another, a C 1 -C 6 alkyl group, a C 2 -C 6 alkenyl group, or a C 2 -C 6 hydroxyalkyl group; Rc represents a C 1 -C 7 alkyl group, a C 8 -C 28 alkyl group,
Imidazoles or their condensed derivatives, e.g. benzimidazoles · CPC title
from other coupling components · CPC title
Quaternary ammonium compounds (A61K8/35 takes precedence) · CPC title
Derivatives containing from 2 to 10 oxyalkylene groups · CPC title
Heterocyclic components · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.